News

Explore the latest news and material from across our business

11 News articles
29th Jun 2021

Dialive ICU therapy features in New Scientist
25th Jun 2021

Novel liver dialysis device shows promise in treating liver failure
24th Jun 2021

Top liver disease conference showcases positive clinical data from Yaqrit’s technologies
17th Mar 2021

A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope
7th Jan 2021

Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
7th Jan 2021

The ALIVER Consortium announces positive results from Phase 2 equivalent trial of the novel liver dialysis device, Dialive™
7th Jan 2021

The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis
27th Aug 2020

Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE
25th Mar 2019

First patient is treated in first-in-human placebo controlled trial investigating safety and tolerability of Carbalive in cirrhosis patients

Our Story

Pipeline

Advanced Liver Disease

Team